← Leaderboards
Nisarg J. Shah
University Of California, San Diego
$1,632,041
Attributed
$1,632,041
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $678.4K · FY2021–24$1M$750K$500K$250K$0
'21
'22
'23
'24
Funding mix
By agency
NIH$1,632,041 · 2
By mechanism
R01$1,345,759 · 1
R03$286,282 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California, San Diego
Same institution · by research overlap
- Scott T Weiss$73,772,324
- Kristin Palmsten$7,540,878
- David A Brenner$18,624,596
- Monica Guma$5,338,014
- Joseph Marco Valentine$111,187
Others in their field
Other Emerging Leaders on “Mediating”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Yunda Huang · Fred Hutchinson Cancer Center$73,602,469
- James Dale Berry · Brigham And Women'S Hospital$25,538,716
- Ionut Bebu · George Washington University$18,816,779
- Barbara Halina Braffett · George Washington University$18,816,779
- Gary Fanger · Rise Therapeutics, Llc$17,847,765
Research focus
MediatingCellsPolymersRegulatory T-LymphocyteIn VivoTissuesDrug Delivery SystemsInflammationPhenotypePathogenicityTretinoinProteinsGlycolatesImmuneAffectCd4 Positive T LymphocytesImmunoregulationInfectionInflammatoryImmune ResponsePreventAutoimmune DiseasesApplications GrantsImmune Modulating Agents
Grant awards (5)
Intra-Articular Drug Delivery Modulating Immune Cells in Inflammatory Joint Disease$667,339
R01 · FY2024 · AR · contact PI
Intra-Articular Drug Delivery Modulating Immune Cells in Inflammatory Joint Disease$449,661
R01 · FY2023 · AR · contact PI
Intra-Articular Drug Delivery Modulating Immune Cells in Inflammatory Joint Disease$228,759
R01 · FY2023 · AR · contact PI
Microparticles Modulating Regulatory T cells in Periodontal Disease$142,778
R03 · FY2022 · DE · contact PI
Microparticles Modulating Regulatory T cells in Periodontal Disease$143,504
R03 · FY2021 · DE · contact PI